MAI Capital Management
FLGT icon

MAI Capital Management’s Fulgent Genetics FLGT Stock Holding History

MAI Capital Management’s Portfolio FLGT Stock Details FLGT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-60
Closed -$954 – 2996
2026
Q1 		$954 Buy
60
+12
+25% +$260 ﹤0.01% 4195
2025
Q4 		$1.26K Hold
48
– – ﹤0.01% 3556
2025
Q3 		$1.08K Sell
48
-145
-75% -$2.99K ﹤0.01% 3482
2025
Q2 		$3.84K Buy
193
+145
+302% +$2.83K ﹤0.01% 3176
2025
Q1 		$812 Hold
48
– – ﹤0.01% 3176
2024
Q4 		$887 Buy
+48
New +$937 ﹤0.01% 3216

Other funds holding FLGT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DC
Diametric Capital Boston, Massachusetts $948M AUM 47.49% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

MAI Capital Management's FLGT Position: Q2 2026 in Review

MAI Capital Management sold out of Fulgent Genetics (FLGT) in Q2 2026, closing a stake of 60 shares — an estimated $954 sold.

MAI Capital Management first reported a position in FLGT in Q4 2024 and held it in 6 quarters. The position peaked at $3.84K in Q2 2025. 141 funds tracked by Wall St. Rank hold FLGT as of Q2 2026.

  • MAI Capital Management reported no remaining Fulgent Genetics position as of Q2 2026 after selling out during the quarter.
  • MAI Capital Management sold 60 Fulgent Genetics shares in Q2 2026, an estimated $954.
  • MAI Capital Management first reported a position in Fulgent Genetics in Q4 2024 and held it in 6 quarters.
  • MAI Capital Management's Fulgent Genetics position peaked at $3.84K in Q2 2025.
  • 141 funds tracked by Wall St. Rank held Fulgent Genetics as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.